BRIEF published on 06/12/2025 at 11:05, 1 year 4 months ago Relief Therapeutics Announces Results of Annual General Meeting Financial Statements Shareholder Approval Annual Meeting Board Elections Compensation Approval
PRESS RELEASE published on 06/12/2025 at 11:00, 1 year 4 months ago Relief Therapeutics Announces Results of Annual General Meeting Relief Therapeutics announces results of its Annual General Meeting with shareholders approving all proposals by a large majority. AGM covers key agenda items and re-election of board members and auditors Board Of Directors Annual General Meeting Shareholders Relief Therapeutics AGM Results
BRIEF published on 05/22/2025 at 07:05, 1 year 4 months ago Relief Therapeutics Secures FDA Rare Pediatric Disease Designation for RLF-TD011 FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease
PRESS RELEASE published on 05/22/2025 at 07:00, 1 year 4 months ago Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 Relief Therapeutics granted FDA Rare Pediatric Disease Designation for RLF-TD011 in treating epidermolysis bullosa, a rare genetic skin disorder. Potent antimicrobial & anti-inflammatory activity shown FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease Designation
BRIEF published on 05/15/2025 at 07:05, 1 year 4 months ago Relief Therapeutics Announces 2025 AGM Agenda Annual General Meeting Financial Statements Shareholder Voting Board Re-election Compensation Approval
PRESS RELEASE published on 05/15/2025 at 07:00, 1 year 4 months ago Relief Therapeutics Publishes 2025 Annual General Meeting Agenda Relief Therapeutics announces agenda for its 2025 Annual General Meeting featuring key resolutions and re-elections. Meeting scheduled for June 12 in Geneva, Switzerland Shareholders Switzerland Relief Therapeutics Agenda 2025 Annual General Meeting
BRIEF published on 04/10/2025 at 07:05, 1 year 6 months ago Relief Therapeutics Announces 2024 Financial Results and Strategic Progress Biopharmaceutical Relief Therapeutics Rare Diseases 2024 Financial Results Pipeline Progress
PRESS RELEASE published on 04/10/2025 at 07:00, 1 year 6 months ago Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
BRIEF published on 03/06/2025 at 07:05, 1 year 7 months ago Relief Therapeutics Ends Merger Discussions with Renexxion Shareholder Value Relief Therapeutics Strategic Objectives Renexxion Merger Termination
PRESS RELEASE published on 03/06/2025 at 07:00, 1 year 7 months ago Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
Published on 10/14/2026 at 14:30, 18 minutes ago Boron One Holdings Inc. Announces Positive Preliminary Economic Assessment (PEA) for Its Piskanja Boron Project
Published on 10/14/2026 at 14:30, 18 minutes ago Predictiv AI Launches Flockentis, Bringing Canadian AI Decision Intelligence to Global Fleet and Logistics Operations
Published on 10/14/2026 at 14:00, 48 minutes ago Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors
Published on 10/14/2026 at 14:00, 48 minutes ago Horizon Aircraft to Participate in Upcoming Industry Events and Investment Conferences
Published on 10/14/2026 at 14:10, 37 minutes ago Q3 2026 J.S. Held AI Disputes Monitor Reveals Shift in AI Litigation from How Systems are Built to How They Behave
Published on 10/14/2026 at 13:15, 1 hour 32 minutes ago Lassa expands its winter tyre range for passenger cars and SUVs with Snoways 5 and Competus Winter 3
Published on 10/14/2026 at 11:12, 3 hours 35 minutes ago Finexity AG: FINEXITY Group signs Letter of Intent with OneCrowd Group – orderly continuity solution planned for issuers and investor base
Published on 10/14/2026 at 11:07, 3 hours 40 minutes ago Peter Schmid von Linstow appointed as new member of the Managing Board and CEO.
Published on 10/14/2026 at 11:05, 3 hours 42 minutes ago Make It Easy to Connect Your Switch to a Larger Screen -- HAILESI S123E Expands into Global Portable Monitor Markets across the UK, Germany, France and Australia, Achieving Top 5 Bestseller Status on Amazon
Published on 10/14/2026 at 10:39, 4 hours 8 minutes ago Number of shares and voting rights - September 2026 (In French only)
Published on 10/13/2026 at 17:45, 21 hours 2 minutes ago ENGIE and CMA CGM join forces to invest in biomethane production in Le Havre
Published on 10/13/2026 at 09:04, 1 day 5 hours ago Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 18:00, 1 day 20 hours ago Invitation - OPmobility’s Q3 2026 Revenue - October 21, 2026
